2017년 FDA 승인 신약 46개: 최근 20년내 최다 개수
FDA approvals hit a 20-year high in 2017,
with cancer and rare-disease drugs dominating the list of new medicines
저분자 합성화합물 신약: 29개(63%)
바이오신약: 17개(37%)After a dip in 2016, 2017 brought a two-decade peak in drug approvals. The U.S. Food & Drug Administration gave its green light to 46 new molecular entities, the highest number since 1996. Cancer treatments and drugs for rare diseases continued to command a hefty portion of approvals, and many benefited from an agency that seems motivated to streamline development for truly innovative medicines. more...